(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 13.43%
Live Chart Being Loaded With Signals
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders...
Stats | |
---|---|
Dagens volum | 68 355.00 |
Gjennomsnittsvolum | 64 922.00 |
Markedsverdi | 24.88M |
EPS | $0 ( 2024-03-08 ) |
Neste inntjeningsdato | ( $-0.680 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.490 |
ATR14 | $0.0520 (1.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-08 | Patel Mahesh V. | Buy | 4 893 | Common Stock |
2024-03-08 | Fogarty Krista | Buy | 991 | Common Stock |
2023-05-25 | Patel Mahesh V. | Buy | 8 706 | Common Stock |
2023-05-10 | Papapetropoulos Spyros | Buy | 30 000 | Stock Option (Right to Buy) |
2023-05-10 | Higuchi John W. | Buy | 30 000 | Common Stock (Right to Buy) |
INSIDER POWER |
---|
93.74 |
Last 96 transactions |
Buy: 4 769 643 | Sell: 1 163 369 |
Volum Korrelasjon
Lipocine Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
SRTS | 0.946 |
CNDT | 0.935 |
TBNK | 0.928 |
SWVL | 0.926 |
VNET | 0.916 |
VTRS | 0.915 |
KOD | 0.915 |
RUBY | 0.915 |
ATHA | 0.914 |
GTEC | 0.912 |
10 Mest negative korrelasjoner | |
---|---|
TYHT | -0.92 |
CNCE | -0.913 |
ZSAN | -0.906 |
EPZM | -0.897 |
VERX | -0.886 |
ORPH | -0.885 |
BIVI | -0.884 |
PLW | -0.883 |
XOG | -0.883 |
BGFV | -0.881 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Lipocine Inc Korrelasjon - Valuta/Råvare
Lipocine Inc Økonomi
Annual | 2023 |
Omsetning: | $109 987 |
Bruttogevinst: | $81 326.00 (73.94 %) |
EPS: | $-3.10 |
FY | 2023 |
Omsetning: | $109 987 |
Bruttogevinst: | $81 326.00 (73.94 %) |
EPS: | $-3.10 |
FY | 2022 |
Omsetning: | $500 000 |
Bruttogevinst: | $-8.06M (-1 611.38 %) |
EPS: | $-2.07 |
FY | 2021 |
Omsetning: | $16 141.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.0000073 |
Financial Reports:
No articles found.
Lipocine Inc
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.